On 2025-11-14, Purple Biotech Ltd. Sponsored ADR (PPBT) announced earnings per share of $-2.90 for the fiscal quarter ending 2025-09-30, missing the average analyst estimate of $-2.60.
The next expected annoucement date for quarterly earnings is 2026-03-09, with an average estimated earnings per share of $-3.40 for the fiscal quarter ending 2025-12-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-11-14 | 2025-09-30 | $-2.60 | $-2.90 |
| 2025-08-06 | 2025-06-30 | $-2.10 | $-4.00 |
| 2025-05-21 | 2025-03-31 | -- | $-1.70 |
| 2025-03-10 | 2024-12-31 | $-2.20 | $-2.60 |
| 2024-11-15 | 2024-09-30 | $-12.00 | $-14.50 |
| 2024-08-16 | 2024-06-30 | $-26.00 | $-16.00 |
| 2024-05-21 | 2024-03-31 | $-30.00 | $-32.00 |
| 2024-03-05 | 2023-12-31 | $-34.00 | $-64.00 |
| 2023-11-21 | 2023-09-30 | $-44.00 | $-46.00 |
| 2023-08-22 | 2023-06-30 | $-50.00 | $-50.00 |
| 2023-05-16 | 2023-03-31 | $-78.00 | $-50.00 |
| 2023-02-08 | 2022-12-31 | $-60.00 | $-60.00 |
| 2022-11-08 | 2022-09-30 | $-44.00 | $-54.00 |
| 2022-08-04 | 2022-06-30 | -- | $-40.00 |
| 2022-05-12 | 2022-03-31 | -- | $-82.00 |